Pseudomonas bacteremia. Retrospective analysis of 410 episodes

Arch Intern Med. 1985 Sep;145(9):1621-9. doi: 10.1001/archinte.145.9.1621.

Abstract

We reviewed 410 episodes of Pseudomonas bacteremia occurring in patients with cancer during a ten-year period. Pseudomonas bacteremia was most common among patients with acute leukemia. The majority of patients acquired their infections in the hospital, and 51% had received antibiotic therapy for other presumed or proved infection during the preceding week. Shock occurred in 33%, and 32% had concomitant pneumonia. The overall cure rate was 62%; it was 67% for patients receiving appropriate antibiotics but only 14% for those receiving inappropriate antibiotics. A one- to two-day delay in the administration of appropriate antibiotic therapy reduced the cure rate from 74% to 46%. Patients who received an antipseudomonal beta-lactam antibiotic with or without an aminoglycoside had a significantly higher cure rate than patients who received only an aminoglycoside (72% and 71% vs 29%). Patients with shock, pneumonia, or persistent neutropenia had a substantially poorer prognosis.

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Drug Resistance, Microbial
  • Female
  • Humans
  • Lactams
  • Leukemia / complications
  • Leukocyte Count
  • Male
  • Middle Aged
  • Neoplasms / complications*
  • Prognosis
  • Pseudomonas Infections / drug therapy
  • Pseudomonas Infections / etiology*
  • Pseudomonas Infections / mortality
  • Pseudomonas aeruginosa / drug effects
  • Retrospective Studies
  • Sepsis / drug therapy
  • Sepsis / etiology*
  • Sepsis / mortality
  • Time Factors

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Lactams